Hematoporphyrin dihydrochloride(CAS: 17696-69-4)

Hematoporphyrin dihydrochloride (CAS: 17696-69-4) falls under GHS classification for hazardous chemicals. It is also subject to REACH regulations in the European Union, which require manufacturers and importers to register substances with the European Chemicals Agency. In the United States, FDA and EPA have specific requirements for the handling and use of this compound in medical and research applications. Ensure compliance by consulting the latest regulatory guidelines and obtaining relevant approvals.

There are several alternatives to Hematoporphyrin dihydrochloride (CAS: 17696-69-4) in synthesis, including porphyrin analogs and other metalloporphyrins. These alternatives offer similar photophysical properties but may differ in stability and reactivity. Common substitutes include mesoporphyrin, protoporphyrin, and chlorin e6, which can be used in similar applications such as photochemical therapy and fluorescence imaging.

The trend for Hematoporphyrin dihydrochloride (CAS: 17696-69-4) is growing due to its applications in photodynamic therapy and fluorescence imaging. Research is focusing on optimizing its use in cancer treatment and diagnosis. Market demand is increasing as more studies validate its efficacy and safety. However, pricing and availability can fluctuate based on supply and demand in the medical and pharmaceutical sectors.

Waste containing Hematoporphyrin dihydrochloride (CAS: 17696-69-4) should be collected in appropriate containers and labeled for hazardous waste. Incineration or professional waste disposal services are recommended to ensure safe and compliant disposal. Environmental protection precautions include following local and national regulations, using personal protective equipment, and minimizing exposure to the compound during handling and disposal processes.